Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 units at $0.30 per unit for aggregate gross proceeds of $1,986,207.
The news comes on the heels of the company's announcement that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. US 20230025693A1, covering the company's deep penetrating topical cannabinoid composition and methods for treating musculoskeletal inflammation and pain.
The Details
Under the offering, each unit is comprised of one common share in the capital of the company and one-half of one common share purchase warrant.
Each warrant entitles the holder to acquire one common share in the ...
